NDC 59148-400 – Voyxact

Sibeprenlimab 200 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC59148-400

Product details

Brand name
Voyxact
Generic name
Sibeprenlimab
Labeler
Otsuka America Pharmaceutical, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761434
Marketed since
November 25, 2025
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Voyxact →

Package NDC codes (1)

Package NDCDescriptionSince
59148-400-751 SYRINGE in 1 CARTON (59148-400-75) / 2 mL in 1 SYRINGENov 25, 2025